Business Context and Reporting Period
This Form 8-K reports on the 2013 Annual Meeting of Stockholders held by Neuralstem, Inc. on June 21, 2013. The filing was submitted on June 24, 2013. Note: The request metadata references "Palisade Bio, Inc.," but the source text explicitly identifies the registrant as Neuralstem, Inc.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results.
Material Changes and Voting Results
As of the record date (April 30, 2013), 68,797,964 shares were outstanding. A quorum was established with 53,088,927 shares represented. The voting outcomes were as follows:
- Proposal 1 (Director Election): Two Class II Director nominees, William Oldaker and Stanley Westreich, were elected to three-year terms.
- Proposal 2 (Equity Plan Amendment): The proposal to increase the number of shares eligible for issuance under the 2010 Equity Compensation Plan by 7,000,000 shares was not approved as it failed to receive a majority of votes.
- Proposal 3 (Auditor Ratification): The ratification of Stegman & Company as the independent registered public accounting firm for the fiscal year ending December 31, 2013, was approved.
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary on financial performance, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the failure of the equity plan amendment (Proposal 2), which may impact future employee compensation structures.
- Confirm the election of William Oldaker and Stanley Westreich to the Board of Directors.
- Note the significant number of non-votes (approx. 41.4 million) on all proposals, indicating substantial broker non-votes or abstentions.
- Clarify the discrepancy between the request metadata (Palisade Bio) and the filing content (Neuralstem, Inc.).